Community News


Market landscape analysis of oncology indications for a small molecule drug

by | January 15, 2018

The project team will conduct a survey to evaluate and prioritize oncological indications to identify promising market entry points for a client’s small molecule lead compound. The team will work closely with the client to select a subset of indications for which the small molecule can provide significant benefit. Team members will utilize secondary and primary research to evaluate the following key areas for each indication: 1) market size and economic burden, 2) unmet need and current standard of care, 3) patient segmentation, and 5) competitive landscape. The team will construct a slide deck summarizing their findings and providing strategic recommendations to guide the client’s internal R&D strategy. A portion of the team’s findings will be synthesized into a market report that will be published on BCBA Viewpoints. The team will work closely with company co-founders and leadership, an industry mentor and Biotech Connection – Bay Area leadership throughout the project.

Project Timeline: End-January to End-April 2018, 12 weeks.

Keywords: oncology, small molecule, market landscape

Eligibility requirements:

  • Applicants must be graduate or professional students (PhD, MD, etc.), postdoc, clinical resident or recent graduate in the Bay Area
  • Time commitment is expected to be 10-15 hrs/wk, and is volunteer based (unpaid).

Preferred Qualifications:

  • Preference will be given to candidates with experience in chemistry, pre-clinical therapeutic development, regulations, oncology, and other related fields.

  • Prior experience in consulting, market research, entrepreneurship, business development, or industry is a plus, but not required.

To Apply:

  • Submit your resume and cover letter to
  • Subject line: Oncology Market
  • Application Deadline: January 15th, 2018